Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2014, Article ID 218628, 3 pages
http://dx.doi.org/10.1155/2014/218628
Case Report

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

1Department of Urology, University of Thrace, 68100 Alexandroupolis, Greece
2Department of Radiotherapy, University of Thrace, 68100 Alexandroupolis, Greece
3Department of Pathology, University of Thrace, 68100 Alexandroupolis, Greece

Received 2 December 2013; Accepted 24 December 2013; Published 29 January 2014

Academic Editors: S. K. Hong and P. M. Pierorazio

Copyright © 2014 Christos Kalaitzis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate. Case Presentation. This case report describes the excellent clinical course of a 68-year-old patient with metastatic mucinous adenocarcinoma of the prostate, treated by radical prostatectomy, irradiation, and androgen deprivation. Conclusion. In our case, mucinous adenocarcinoma of the prostate does not appear to behave differently than acinar prostate cancer. Its malignant potential is dependent on its Gleason score.